Insights into Chimeric Antigen Receptor Therapy for Chronic Lymphoblastic Leukemia

被引:0
|
作者
Hamieh, Mohamad [1 ]
Sadelain, Michel [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA
关键词
D O I
10.1016/j.molmed.2018.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a recent study, Fraietta and colleagues identified chimeric antigen receptor (CAR) T cell biomarkers that may predict the success or failure of CAR therapy in patients with refractorychroniclymphoblastic leukemia (CLL). These findings open new prospects for improving T cell product manufacturing and the management of patients with CLL undergoing T cell-based therapies.
引用
下载
收藏
页码:729 / 731
页数:3
相关论文
共 50 条
  • [21] Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia
    Myers, Regina M.
    Dolan, Joseph
    Teachey, David T.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (10) : 1029 - 1042
  • [22] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [23] Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
    Beyar-Katz, Ofrat
    Rowe, Jacob M.
    HAEMATOLOGICA, 2024, 109 (06) : 1631 - 1633
  • [24] Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia
    Ceppi, Francesco
    Gardner, Rebecca A.
    CANCER JOURNAL, 2019, 25 (03): : 191 - 198
  • [25] Chimeric antigen receptor T-cell neuropsychiatric toxicity in acute lymphoblastic leukemia
    Prudent, Vasthie
    Breitbart, William S.
    PALLIATIVE & SUPPORTIVE CARE, 2017, 15 (04) : 499 - 503
  • [26] Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia
    Emole, Josephine
    Lawal, Odunayo
    Lupak, Oleksandra
    Rangarajan, Hemalatha
    Udo, Itoro
    LEUKEMIA RESEARCH REPORTS, 2023, 19
  • [27] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang Xian
    Li Jing-Jing
    Lu Pei-Hua
    中华医学杂志(英文版), 2020, 133 (04) : 474 - 482
  • [28] The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
    Ragoonanan, Dristhi
    Sheikh, Irtiza N.
    Gupta, Sumit
    Khazal, Sajad J.
    Tewari, Priti
    Petropoulos, Demetrios
    Li, Shulin
    Mahadeo, Kris M.
    BIOMEDICINES, 2022, 10 (09)
  • [29] Acute Kidney Injury after Chimeric Antigen Receptor T-Cell Therapy for Pediatric Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Fitzgerald, Julie
    Elgarten, Caitlin W.
    Getz, Kelly D.
    Li, Yimei
    Hogan, Jonathan
    Dinofia, Amanda
    Burrows, Evanette K.
    Aplenc, Richard
    Grupp, Stephan A.
    Laskin, Benjamin
    Maude, Shannon L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [30] Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (06) : 1347 - 1356